Edition:
United Kingdom

Cytori Therapeutics Inc (CYTX.OQ)

CYTX.OQ on NASDAQ Stock Exchange Capital Market

0.25USD
8:59pm GMT
Change (% chg)

$-0.01 (-4.73%)
Prev Close
$0.26
Open
$0.27
Day's High
$0.27
Day's Low
$0.25
Volume
133,936
Avg. Vol
182,683
52-wk High
$2.13
52-wk Low
$0.25

Revenue & Earnings Per Share

 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 2 2.77 3.24 2.30 2.91
Quarter Ending Mar-18 2 2.78 2.79 2.78 2.86
Year Ending Dec-17 2 6.87 7.22 6.52 9.21
Year Ending Dec-18 2 13.67 13.89 13.45 23.42
Earnings (per share)
Quarter Ending Dec-17 2 -0.10 -0.05 -0.15 -0.19
Quarter Ending Mar-18 2 -0.10 -0.03 -0.17 -0.18
Year Ending Dec-17 1 -0.61 -0.61 -0.61 -0.90
Year Ending Dec-18 2 -0.38 -0.11 -0.64 -0.26
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.16 32.93
P/E High - Last 5 Yrs. -- 40.81 45.62
P/E Low - Last 5 Yrs. -- 20.30 24.34
Beta 2.49 0.79 0.88
Price to Sales (TTM) 2.07 7.47 5.40
Price to Book (MRQ) 0.07 13.30 5.38
Price to Tangible Book (MRQ) 1.19 25.48 6.78
Price to Cash Flow (TTM) -- 21.76 23.45
% Owned Institutions -- 3.28 1.40

Dividends

  Company industry sector
Dividend Yield -- 1.02 1.50
Dividend Yield - 5 Year Avg 0.00 1.20 1.52
Dividend 5 Year Growth Rate -- 17.03 5.17
Payout Ratio(TTM) -- 29.72 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -11.85 8.52 9.00
Sales (TTM) vs TTM 1 Yr. Ago -27.85 1.89 5.38
Sales - 5 Yr. Growth Rate 12.09 8.72 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 20.16 51.53 19.67
EPS (TTM) vs TTM 1 Yr. Ago 7.96 -- --
EPS - 5 Yr. Growth Rate -- 19.69 10.79
Capital Spending - 5 Yr. Growth Rate -19.87 8.56 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.20 2.40 2.18
Current Ratio (MRQ) 4.46 3.15 2.98
LT Debt to Equity (MRQ) 57.95 29.52 11.56
Total Debt to Equity (MRQ) 86.16 35.99 15.81
Interest Coverage (TTM) -3.51 16.05 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 63.23 58.76 54.83
Gross Margin - 5 Yr. Avg. 46.26 58.50 52.40
EBITD Margin (TTM) -241.34 -- --
EBITD - 5 Yr. Avg -273.64 23.43 15.24
Operating Margin (TTM) -238.29 17.91 7.76
Operating Margin - 5 Yr. Avg. -289.78 16.28 10.75
Pre-Tax Margin (TTM) -258.72 17.70 8.57
Pre-Tax Margin - 5 Yr. Avg. -291.97 16.57 11.17
Net Profit Margin (TTM) -258.72 13.59 4.88
Net Profit Margin - 5 Yr. Avg. -291.97 11.61 7.47
Effective Tax Rate (TTM) -- 22.85 23.11
Effective Tax Rate - 5 Yr. Avg. -- 29.04 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 73,043 27,385,026 864,673,366
Net Income/Employee (TTM) -188,977 3,271,439 101,717,513
Receivable Turnover (TTM) 5.74 5.05 5.76
Inventory Turnover (TTM) 1.31 3.14 3.34
Asset Turnover (TTM) 0.23 0.78 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -60.36 10.55 11.00
Return on Assets - 5 Yr. Avg. -93.65 9.14 12.43
Return on Investment (TTM) -78.90 14.01 14.46
Return on Investment - 5 Yr. Avg. -129.83 11.82 16.28
Return on Equity (TTM) -286.17 16.85 16.05
Return on Equity - 5 Yr. Avg. -- 14.12 17.51
  1 Year 3 Year 5 Year
Sales % -27.85 20.66 12.09
EPS (TTM) % 7.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cytori Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.